Click here to have a similar quality,and unique paper at a discount

PHARM NURS6521

•    Question 1
1 out of 1 points
    
    What will the PMHNP most likely prescribe to a patient with psychotic aggression who needs to manage the top-down cortical control and the excessive drive from striatal hyperactivity?            

            
•    Question 2
1 out of 1 points
    
    The PMHNP is selecting a medication treatment option for a patient who is exhibiting psychotic behaviors with poor impulse control and aggression. Of the available treatments, which can help temper some of the adverse effects or symptoms that are normally caused by D2 antagonism?
            

            
•    Question 3
1 out of 1 points
    
    The PMHNP is discussing dopamine D2 receptor occupancy and its association with aggressive behaviors in patients with the student. Why does the PMHNP prescribe a standard dose of atypical antipsychotics?            
    Selected Answer:    C. 
The doses are based on achieving 60% D2 receptor occupancy.

            
•    Question 4
1 out of 1 points
    
    Why does the PMHNP avoid prescribing clozapine (Clozaril) as a first-line treatment to the patient with psychosis and aggression?            

            
•    Question 5
1 out of 1 points
    
    The PMHNP is caring for a patient on risperidone (Risperdal). Which action made by the PMHNP exhibits proper care for this patient? </p?            

            
•    Question 6
1 out of 1 points
    
    The PMHNP wants to prescribe Mr. Barber a mood stabilizer that will target aggressive and impulsive symptoms by decreasing dopaminergic neurotransmission. Which mood stabilizer will the PMHNP select?
            

            
•    Question 7
1 out of 1 points
    
    The parents of a 7-year-old patient with ADHD are concerned about the effects of stimulants on their child. The parents prefer to start pharmacological treatment with a non-stimulant. Which medication will the PMHNP will most likely prescribe?
            

            
•    Question 8
1 out of 1 points
    
    The PMHNP understands that slow-dose extended release stimulants are most appropriate for which patient with ADHD?            

            
•    Question 9
1 out of 1 points
    
    A patient is prescribed D-methylphenidate, 10-mg extended-release capsules. What should the PMHNP include when discussing the side effects with the patient?              
    

            
•    Question 10
1 out of 1 points
    
    The PMHNP is teaching parents about their child’s new prescription for Ritalin. What will the PMHNP include in the teaching?             

            
•    Question 11
1 out of 1 points
    
    A young patient is prescribed Vyvanse. During the follow-up appointment, which comment made by the patient makes the PMHNP think that the dosing is being done incorrectly?            

            
•    Question 12
1 out of 1 points
    
    A 14-year-old patient is prescribed Strattera and asks when the medicine should be taken. What does the PMHNP understand regarding the drug’s dosingprofile?
            

            
•    Question 13
0 out of 1 points
    
    The PMHNP is meeting with the parents of an 8-year-old patient who is receiving an initial prescription for D-amphetamine. The PMHNP demonstratesappropriate prescribing practices when she prescribes the following dose:              

            
•    Question 14
1 out of 1 points
    
    A patient is being prescribed bupropion and is concerned about the side effects. What will the PMHNP tell the patient regarding bupropion?            
    
            
•    Question 15
1 out of 1 points
    
    Which patient will receive a lower dose of guanfacine?            

            
•    Question 16
1 out of 1 points
    
    An 18-year-old female with a history of frequent headaches and a mood disorder is prescribed topiramate (Topamax), 25 mg by mouth daily. The PMHNP understands that this medication is effective in treating which condition(s) in this patient?            

            
•    Question 17
1 out of 1 points
    
    The PMHNP is treating a patient for fibromyalgia and is considering prescribing milnacipran (Savella). When prescribing this medication, which action is the PMHNP likely to choose?
            

            
•    Question 18
1 out of 1 points
    
    The PMHNP is assessing a patient she has been treating with the diagnosis of chronic pain. During the assessment, the patient states that he has recently been having trouble getting to sleep and staying asleep. Based on this information, what action is the PMHNP most likely to take?
            

            
•    Question 19
1 out of 1 points
    
    The PMHNP is assessing a female patient who has been taking lamotrigine (Lamictal) for migraine prophylaxis. After discovering that the patient has reached the maximum dose of this medication, the PMHNP decides to change the patient’s medication to zonisamide (Zonegran). In addition to evaluating this patient’s day-to-day activities, what should the PMHNP ensure that this patient understands?
            

            
•    Question 20
1 out of 1 points
    
    A patient recovering from shingles presents with tenderness and sensitivity to the upper back. He states it is bothersome to put a shirt on most days. This patient has end stage renal disease (ESRD) and is scheduled to have hemodialysis tomorrow but states that he does not know how he can lie in a recliner for 3 hours feeling this uncomfortable. What will be the PMHNP’s priority?

Nursing study quiz
Click here to have a similar quality,and unique paper at a discount

Latest completed orders:

Completed Orders
# Title Academic Level Subject Area # of Pages Paper Urgency